Renal implications of pneumoperitoneum in laparoscopic surgery:  mechanisms, risk factors, and preventive strategies

Gianluca Villa; Marco Fiorentino; Eleonora Cappellini; Sergio Lassola; Silvia De Rosa

doi:10.4097/kja.24011

Korean J Anesthesiol > Volume 77(6); 2024 > Article

Villa, Fiorentino, Cappellini, Lassola, and De Rosa: Renal implications of pneumoperitoneum in laparoscopic surgery: mechanisms, risk factors, and preventive strategies

Review Article

Korean Journal of Anesthesiology 2024;77(6):575-586.

Published online: April 26, 2024

DOI: https://doi.org/10.4097/kja.24011

Renal implications of pneumoperitoneum in laparoscopic surgery: mechanisms, risk factors, and preventive strategies

Gianluca Villa^1,²

, Marco Fiorentino³

, Eleonora Cappellini¹

, Sergio Lassola⁴

, Silvia De Rosa^4,⁵

¹Department of Health Sciences, Anesthesiology Intensive Care and Pain Medicine, University of Florence, Florence, Italy

²Department of Anesthesia and Intensive Care, Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy

³Department of Precision and Regenerative Medicine and Ionian Area, Nephrology Unit, University of Bari, Italy

⁴Anesthesia and Intensive Care, Santa Chiara Regional Hospital, APSS Trento, Italy

⁵Center for Medical Sciences - CISMed, University of Trento, Trento, Italy

Corresponding author: Silvia De Rosa, M.D.

Center for Medical Sciences – CISMed, The University of Trento, Via S. Maria Maddalena 1, 38122 Trento, Italy

Tel: +39-3933098583

Fax: +0557946211

Email: derosa.silvia@gmail.com; silvia.derosa@unitn.it

Received February 8, 2024 Revised April 9, 2024 Accepted April 12, 2024

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Pneumoperitoneum, which is established for laparoscopic surgery, has systemic implications on the renal system and may contribute to acute kidney injury or postoperative renal dysfunction. Specifically, when the pressure exceeds 10 mmHg, pneumoperitoneum decreases renal blood flow, leading to renal dysfunction and temporary oliguria. The renal effects of pneumoperitoneum stem from both the direct effects of increased intra-abdominal pressure and indirect factors such as carbon dioxide absorption, neuroendocrine influences, and tissue damage resulting from oxidative stress. While pneumoperitoneum can exacerbate renal dysfunction in patients with pre-existing kidney issues, preserving the function of the remaining kidney is crucial in certain procedures such as laparoscopic live donor nephrectomy. However, available evidence on the effects of pneumoperitoneum on renal function is limited and of moderate quality. This review focuses on exploring the pathophysiological hypotheses underlying kidney damage, mechanisms leading to oliguria and kidney damage, and fluid management strategies for surgical patients during pneumoperitoneum.

Keywords: Acute kidney injury; Biomarkers; Elective surgical procedures; Pneumoperitoneum; Renal plasma flow; Robot-assisted surgery; Robotic surgical procedures.

Introduction

Pneumoperitoneum, which is established for laparoscopic surgery, has a systemic impact on the renal system and may contribute to acute kidney injury (AKI) or postoperative renal dysfunction. Specifically, when the pressure exceeds 10 mmHg, pneumoperitoneum can result in reduced renal blood flow, renal dysfunction, and transient oliguria. The mechanisms underlying the renal effects of pneumoperitoneum include both the direct effects of elevated intra-abdominal pressure (IAP) and indirect factors such as carbon dioxide (CO₂) absorption, neuroendocrine influences, and tissue damage secondary to oxidative stress. As patients with preexisting renal dysfunction may experience further deterioration due to pneumoperitoneum, preserving the function of the remaining kidney is crucial in procedures such as laparoscopic live-donor nephrectomy.

Despite extensive research, the mechanisms underlying the renal effects of pneumoperitoneum have not been fully elucidated. Available evidence of its effects on renal function is limited and of moderate quality [1]. Although the adverse effects of pneumoperitoneum on serum creatinine (sCr) levels, renal blood flow, and urine output (UO) are apparent, the reliability and clinical relevance of these findings are not well understood, as the long-term effects of pneumoperitoneum have not been assessed [2].

This review aims to delve into the pathophysiological hypothesis of kidney damage, mechanisms leading to oliguria and kidney damage, and fluid management in surgical patients during pneumoperitoneum.

Epidemiology of AKI for laparoscopic procedures

The incidence of AKI varies considerably, ranging from 0.8% to 22.4% after abdominal surgery [3–6] and from 3.4% to 8.8 % after laparoscopic surgery [7–13]. This variability stems from differences in AKI diagnostic criteria, study designs, and patient characteristics, which collectively influence the reported incidence rates and complicate comparisons between studies. The adoption of the Kidney Disease Improving Global Outcomes (KDIGO) criteria [14] has notably affected AKI incidence rates. Studies applying the KDIGO criteria often report higher incidences of postoperative AKI due to its greater sensitivity, which is attributed to the minimal change in sCr required for diagnosis. For instance, in two cohorts of similar patients undergoing laparoscopic abdominal surgery, Sim et al. [7] and Abdullah et al. [8] reported postoperative AKI incidences of 8.8% and 2.9%, respectively, using the KDIGO definition and its modified version. The KDIGO criteria has been found to be inconsistent with other diagnostic criteria, such as the Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE) or the Acute Kidney Injury Network (AKIN) definitions.

Furthermore, the approach to AKI diagnosis, whether prospective or retrospective, significantly influences the reported incidence rates. The prospective inclusion of both UO and sCr criteria, as per the KDIGO definition, has resulted in higher incidence of AKI than retrospective assessments based on creatinine assessments over time [9–11]. For instance, Srisawat et al. [9] reported an AKI incidence of 35% using the KDIGO criteria in a single-center prospective study, whereas retrospective studies adopting the same criteria reported lower incidences ranging from 3.9% [10] to 9.9% [11], despite enrolling comparable patient cohorts. Moreover, studies focusing solely on sCr for AKI definition have reported even lower incidences of postoperative AKI, such as the 3.4% and 1.6% reported by Park et al. [12] and Moon et al., [13] respectively. These retrospective studies included patients with a high risk of AKI, including those undergoing laparoscopic pancreaticoduodenectomy and liver resection.

Direct effect of CO₂

Carbon dioxide (CO₂), which was introduced to establish pneumoperitoneum in the 1920s, is the most suitable gas for insufflation into the abdominal cavity (pneumoperitoneum of 8–20 mmHg) [15]. Although CO₂ is non-toxic and non-flammable, its high solubility in blood and tissues, easy elimination through the lungs, and cost-effectiveness make it an optimal choice [16,17]. Direct and indirect physiological changes in the kidneys are associated with CO₂ insufflation, which activates significant mechanical and neurohumoral mechanisms. Regional perfusion of the kidneys occurs in four structurally distinct vascular zones: the cortex, outer stripe of the medulla, inner stripe of the outer medulla, and inner medulla [18]. A pressure of 20 mmHg during insufflation causes a 60% decrease in the renal blood flow, leading to a blood shift from the outer cortex to the juxtamedullary zone. This shift adversely affects filtration because the majority of the glomeruli are located in the cortex [18]. Both robotic and laparoscopic procedures result in a 20%–40% decrease in the glomerular filtration rate (GFR) and a 60%–80% decrease in UO when the pressure exceeds 10 mmHg, as demonstrated in experimental and clinical studies. Fig. 1 illustrates the renal effects of CO₂ pneumoperitoneum. In a systematic review and meta-analysis of animal studies, Wever et al. [2] found robust evidence of harmful effects on renal function and perfusion during pneumoperitoneum; however, data on long-term effects are limited. Another systematic review by Demyttenaere et al. [19] found a transitory reduction in renal blood flow in 17 of the 20 examined studies. Factors such as insufflation pressure, patient positioning (worse in the head-up position), and fluid status were identified as significant contributors to decreased renal blood flow. Long-term effects indicated that sCr normalized 24 h after pneumoperitoneum insufflation at 15 mmHg. Bilgic et al. [20] found a correlation between increased levels of KIM-1 and creatinine, which is consistent with histopathological analyses. Additionally, the IAP was found to significantly increase the degree of kidney injury, even when KIM-1 levels were not significantly increased.

Pathophysiological hypothesis of kidney damage

The pathophysiological hypothesis of kidney damage in surgical patients, particularly those undergoing laparoscopic procedures, encompasses various mechanisms, including renal hypoperfusion, cellular hypoxia, inflammation, and direct toxicity.

The primary mechanism of tubular epithelial cell injury during kidney hypoperfusion involves a mismatch between oxygen and nutrient supplies and the metabolic demand of renal cells. A reduction in the mean arterial pressure (MAP) is a significant cause of decreased renal perfusion pressure, similar to the effect occurring during pneumoperitoneum. Specifically, the pressure applied to the renal parenchyma due to pneumoperitoneum results in reduced renal blood flow [21]. Locally regulated activation of myogenic-induced vasodilation may ensure a transient increase in renal blood flow in patients with physiological renal functional reserve (RFR), thereby maintaining a normal GFR range [22]. Elderly patients with multiple comorbidities, often undergoing laparoscopic surgery, have a limited RFR, making them prone to intraoperative insult to the kidney (Fig. 2). Persistent insults to the kidney can lead to tubular apoptosis, necrosis, and electrolyte imbalance and electrolyte and water homeostasis impairments are associated with reduced waste product elimination [21]. Postoperative AKI is thus typically diagnosed. Prolonged reduction in renal perfusion pressure [19] during pneumoperitoneum in patients with impaired myogenic adaptive mechanisms may further contribute to ischemic reperfusion insults (Fig. 2) [23]. This, in turn, triggers a dysregulated inflammatory response [24], including the activation of neutrophils (as well as macrophages and natural killer, T, and B cells) [25] and the release of reactive oxygen species (ROS) or other inflammatory mediators that promote endothelial cell injury and swelling [26,27].

Patients undergoing laparoscopic or robot-assisted surgery may also experience additional nephrotoxic injuries, including exposure to certain intraoperative agents, promotion of renal vasoconstriction, and direct proximal tubule cytotoxicity (Fig. 2) [28].

Inflammation-derived damage and metabolic abnormalities contribute significantly to kidney damage triggered by proinflammatory molecules [29,30] during pneumoperitoneum-induced AKI [31]. Notably, the kidneys require a large amount of energy from adenosine triphosphate for active water and solute transport, which is facilitated by its extensive mitochondrial presence [32]. Disruption of physiological proton pumping across the inner mitochondrial membrane can lead to subsequent mitochondrial dysfunction, exacerbating cell damage through the production of ROS and the release of pro-apoptotic or proinflammatory factors, such as mitochondrial DNA (Fig. 2) [33].

Oliguria can develop irrespective of the gas type used for insufflation. An ideal insufflation gas should be cost-effective, colorless, non-flammable, non-explosive, easily eliminated, and non-toxic. CO₂ is a remarkably soluble gas, with a solubility coefficient of 0.570, and is absorbed by the peritoneum, delivered directly to the lungs through circulation, and excreted by the lungs during respiratory exchange [34]. However, CO₂ is not a perfect gas and its absorption can lead to hypercapnia and acidosis, necessitating counteractive hyperventilation [15]. CO₂ is also associated with an increase in the MAP, and in cases of high blood concentrations, it can result in cardiac toxicity. Although the direct effects of CO₂ pneumoperitoneum on renal blood flow have been considered, CO₂-related cardiovascular effects may indirectly affect renal function.

Several gases (e.g., helium, argon, nitrogen, nitrous oxide, and room air) have been introduced as alternatives to carbon dioxide for establishing pneumoperitoneum [35]; however, their use remains controversial. Helium and argon are inert gases but are less soluble than CO₂, potentially increasing the risk of venous gas embolism [36]. Nitrous oxide (i.e., laughing gas) is a mild anesthetic with analgesic properties [35]. However, two cases of explosions using electrocautery during laparoscopy have been reported [37]. Recently, Yu et al. [38] reported no severe side effects related to the use of CO₂, nitrous oxide, or room air, although severe side effects do occur rarely. The effects of nitrous oxide and helium pneumoperitoneum are not well understood compared with those of CO₂ pneumoperitoneum. Evidence from one trial with a small sample size suggested that room-air pneumoperitoneum may decrease hospital costs for patients undergoing laparoscopic abdominal surgery. The safety of nitrous oxide, helium, and room-air pneumoperitoneum is yet to be established.

Conversely, compared to open procedures, robotic and laparoscopic surgeries offer reduced postoperative pain as they do not suppress the immune system as significantly [39]. They also exhibit a lower elevation of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-1, and tumor necrosis factor-alpha (TNF-α), along with decreased C-reactive protein levels.

Although CO₂ pneumoperitoneum induces a lower release of IL-6 compared to room air, TNF-α levels may vary depending on pneumoperitoneum pressure [40]. Higher plasma TNF-α levels were found in rats undergoing a pneumoperitoneum pressure of 10 mmHg than in those undergoing a pressure of 6 mmHg and control groups [41]. Surgery causes an immediate elevation of stress hormone levels and decreases the immune response [42]. A systemic stress response related to pneumoperitoneum is evoked by an increase in IAP from baseline to 20 mmHg [43]. Remarkably, an increase in IAP increases plasma epinephrine and norepinephrine levels and does not depend on the type of gas used [44]. However, in the open surgical approach, adrenocortical hormone, cortisol, norepinephrine, epinephrine, insulin, and blood sugar levels increase and remain elevated during the first 24 h postoperatively [45].

Conversely, in pneumoperitoneum, elevated levels of vasopressin or antidiuretic hormone (ADH) are associated with an increase in systemic vascular resistance [46]. However, intra-abdominal pH changes secondary to pneumoperitoneum can stimulate the activation of peritoneal nerve endings, leading to intra-abdominal pH changes and release of vasopressin via the neurogenic vagal pathway [47]. In addition, decreased venous return stimulates right atrial volume receptors, triggering the release of vasopressin/ADH. This results in decreased UO, although fluid replacement increases the risk of fluid overload [48]. The systemic stress response resolves in the immediate postoperative period, after pneumoperitoneum resolution (Fig. 1).

Risk factors for AKI during pneumoperitoneum

Risk factors for AKI during pneumoperitoneum in minimally invasive surgery include CO₂ insufflation and elevated IAP. While the kidneys are susceptible to pressure changes, risk factors such as dehydration, older age, and pre-existing chronic kidney disease (CKD) affect the RFR [49]. However, assessing changes in renal function during laparoscopic procedures is challenging because no specific markers for monitoring rapid changes in GFR in clinical practice are known. Both pre-clinical and clinical studies have shown transient worsening of renal function with oliguria and reduced GFR (5). Preexisting CKD is a crucial risk factor for AKI in pneumoperitoneum. Cisek et al. [50] investigated the changes in renal function during and after pneumoperitoneum in a swine model with reduced renal mass, suggesting that pneumoperitoneum had an impact on the onset of AKI, with no identified long-term consequences. Abboud et al. [51] found a direct correlation between IAP elevation and AKI development, particularly in diabetic rats, which are sensitive to the deleterious effects of pneumoperitoneum. A case report demonstrated progression to end-stage renal disease in a patient with preexisting CKD after laparoscopic surgery. Moreover, renin-angiotensin-aldosterone system inhibitors pose another risk factor as they affect hemodynamic changes during laparoscopic procedures [52]. Lindstrom et al. [53] reported oliguria and a reduced GFR in rats treated with angiotensin-converting enzyme inhibitors, underscoring the need to discontinue such treatment during conditions characterized by elevated IAP to maintain adequate renal perfusion. Recently, the incidence of postoperative AKI between laparoscopic and open surgery in patients with colorectal cancer has been investigated, with no significant differences in such outcomes reported. At the same time, ICU admission, length of hospital stay, and 1-year mortality were better in the laparoscopic group. Additionally, the same report highlighted that a high body mass index (BMI), preoperative hypoalbuminemia, history of diabetes mellitus, and hypertension were significantly associated with the onset of postoperative AKI. Table 1 summarizes the risk factors and bundles for AKI. The use of validated risk scores for postoperative AKI is suggested to better stratify patients and facilitate the application of interventions targeting specific modifiable risk factors.

Diagnosis of acute kidney injury

Urinary output and serum creatinine

UO and sCr levels are pivotal for defining and grading AKI according to the KDIGO guidelines [14]. In perioperative settings, changes in the UO or sCr levels signal potential kidney insults and aid in the identification of postoperative AKI [54]. However, although these markers are commonly used, they have limitations as indicators of kidney damage, mainly reflecting alterations in kidney function due to stressors. sCr levels are used to determine the estimated glomerular filtration rate (eGFR); however, confounding factors such as race, sex, age, perioperative malnutrition, sarcopenia, or hydration status can exert an influence [55]. Preoperative sCr levels reflect baseline kidney function, but do not provide information about the presence or amount of renal adaptability to insults (i.e., RFR). Patients with limited RFR may exhibit average sCr levels preoperatively but are vulnerable to acute function reduction post-insult, marked by increased sCr levels and reduced UO. sCr elevation manifests more slowly in kidney dysfunction than reduced UO. In cases of limited RFR, pneumoperitoneum can swiftly induce kidney dysfunction, causing intraoperative oliguria and a subsequent increase in sCr levels postoperatively. According to the KDIGO definition, the severity of AKI should consider the patient’s muscle mass and hydration status when using sCr levels. UO is a sensitive kidney function parameter and a tubular injury marker [56]. Intraoperative oliguria due to volume depletion and reduced renal blood flow may not indicate kidney damage, but is crucial for identifying AKI, particularly in patients with limited RFR or pneumoperitoneum-related stressors [57]. In patients with a reduced RFR or multiple stressors related to pneumoperitoneum, this physiologic reaction may lead to a UO reduction below 0.5 ml/kg/h for at least 6 h, effectively identifying AKI according to the KDIGO criteria [14]. In major abdominal laparoscopic or robot-assisted surgeries, preoperative fasting exacerbates the antidiuretic state caused by manipulation of the viscera and peritoneum [58], along with reflex vasoconstriction mediated by neuroendocrine activation, surgical trauma, blood loss, insensitive fluid loss, and mechanical ventilation [58,59]. Monitoring UO using a urinary catheter is feasible during these procedures, with reports of intraoperative oliguria in both animal models and humans undergoing laparoscopic surgery [60,61]. A systematic review by Demyttenaere et al. [19] found that six human studies revealed decreased renal function during pneumoperitoneum, as indicated by a reduced GFR and UO. Intraoperative UO shows promise as a diagnostic tool during the perioperative period. While intraoperative oliguria may not consistently correlate with postoperative AKI, recent research, such as that conducted by Milder et al. [62], has demonstrated a link between intraoperative oliguria and an increased incidence of postoperative AKI in major abdominal surgeries.

Biomarker levels after robot-assisted laparoscopic and laparoscopic surgery

Minimally invasive surgery is gaining popularity because of its association with oliguria, decreased GFR, and altered renal perfusion [63]. Laparoscopic surgery, aided by advances in anesthesia, reduces surgical trauma, complications, and postoperative pain compared to traditional methods. However, robotic systems featuring 3D imaging and articulated instruments offer advantages over conventional laparoscopy [64]. Various surgical scenarios have been investigated for renal biomarkers during laparoscopic or robotic procedures. This review focuses on neutrophil gelatinase-associated lipocalin (NGAL), a 25-kDa protein primarily generated in neutrophil granules and nephrons in response to tubular epithelium damage [65]. NGAL exhibits a sensitivity of 84% and specificity of 94% in detecting AKI with a cut-off ≥ 150 ng/ml of plasma NGAL [66]. Postoperative serum NGAL levels were higher after retropubic radical prostatectomy than after robot-assisted laparoscopic prostatectomy, potentially because variances in the surgical approach affected renal physiology. The laparoscopic approach often involves pneumoperitoneum, which induces an IAP exceeding 15 mmHg, thereby reducing the cardiac output and renal blood flow [67].

Additionally, restrictive fluid administration may exacerbate renal impairment [68]. Shalabi et al. [69] demonstrated a negative effect of pneumoperitoneum on kidney function in patients undergoing laparoscopic nephrectomy compared with the open procedure. Although urinary NGAL levels were not affected by increased IAP, these data should be confirmed in a prospective randomized study. In their longitudinal prospective study, Orsolya et al. [70] compared the effects of two anesthetic techniques (general vs. combined) on the plasma levels of NGAL after robotic urogenital surgery. Impairment of renal function and AKI occurred in robot-assisted laparoscopy under both general and combined anesthesia. However, the plasma levels of NGAL were significantly higher at 6 and 12 h in the general anesthesia group than in the combined anesthesia group. The authors did not report pneumoperitoneum levels or possible direct renal effects of CO₂. Consequently, understanding the specific effects of the anesthetic or sedative agents used during surgery is essential, especially in relation to their potential renoprotective roles during procedures involving pneumoperitoneum. This connection underscores the importance of detailed monitoring and reporting of all factors influencing renal function in surgical settings.

Recently, Sun et al. [71] found that dexmedetomidine (DEX) plays a protective role in kidney and other organ functions in patients undergoing elective laparoscopic surgery for colorectal cancer. DEX treatment significantly decreased serum NGAL levels measured 1 and 5 days postoperatively, consistent with preclinical studies that documented the protective role of DEX against ischemia/reperfusion injury in animal kidneys [72]. In 2014, the US Food and Drug Administration (FDA) approved the marketing of a test based on the combination of urine concentrations of urinary tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP-7) to determine the risk of developing moderate-to-severe AKI [73]. The role of these biomarkers in the diagnosis, management, and prognosis of AKI was analyzed in different clinical settings [74–77]. Although a recent meta-analysis demonstrated that urine TIMP-2 and IGFBP7 levels are promising candidates for the early detection of AKI in different settings [78], it has never been tested in patients undergoing laparoscopic or robotic surgery. Further studies on TIMP-2 and IGFBP7 are needed to assess the effect of pneumoperitoneum and the possible direct renal effects of CO₂ in patients undergoing laparoscopic and robotic surgery.

Prevention of AKI

Preventing AKI is paramount in laparoscopic surgery, and KDIGO bundles have been shown to be essential [55]. Despite it being minimally invasive, laparoscopic surgery introduces challenges such as pneumoperitoneum and nephrotoxic agents. The application of the KDIGO bundle is a potent strategy for mitigating the risk of AKI [55,79]. Preoperative assessment of AKI risk factors, including age, renal conditions, diabetes, and hypertension, is crucial for tailoring prevention strategies. The KDIGO bundle targets potential AKI triggers and emphasizes the need for hemodynamic support for adequate renal perfusion. Maintaining optimal fluid balance, a key component of the bundle, is vital in laparoscopic surgery, balancing hydration and avoiding fluid overload amidst pneumoperitoneum [80]. Renal dysfunction may occur in the context of restrictive fluid administration (with consequent hypotension and renal hypoperfusion) or more liberal fluid approaches (with consequent pulmonary and organ congestion) [81]. Choosing an appropriate fluid solution is crucial, as recent evidence suggests an association between certain solutions and increased risk of AKI [82,83].

Additionally, careful consideration of medications and contrast agents is necessary to avoid nephrotoxic agents whenever possible and to closely monitor sCr levels and UO postoperatively to detect AKI early [84]. The KDIGO bundle recommends avoiding nephrotoxic agents whenever possible, opting for alternatives or adjusting dosages. The use of bicarbonate or N-acetylcysteine is not supported by strong clinical evidence, and preventive measures continue to be based on hydration therapy [85]. Close monitoring of sCr levels and UO in the postoperative phase is indispensable for early detection of AKI. Furthermore, the use of other potential nephrotoxic drugs should be considered to avoid further insults to renal function [79]. The adequate use of antibiotic treatment and the judicious use of pain management techniques to encourage early mobilization further aid in reducing the risk of AKI. The recent introduction of urinary biomarkers such as TIMP-2 and IGFBP7 has enhanced the early detection and prevention of AKI. Additionally, the application of a biomarker-triggered KDIGO bundle has shown promising results in reducing the incidence of AKI in various surgical settings, emphasizing the importance of these biomarkers in guiding AKI prevention strategies [86–89].

Fluid therapy management plays a pivotal role in patients with AKI by balancing the preservation of intravascular volume and systemic hemodynamics while avoiding hemodilution and fluid overload. The timing and modalities of fluid management require careful consideration, especially in patients with impaired cardiac function, because fluid overload is associated with increased mortality and hinders renal recovery after AKI [90,91]. Individualizing fluid administration based on the patient’s condition and the phase of critical illness is crucial, considering factors such as diuretic resistance and the multifactorial nature of AKI [92,93]. Oliguric patients may not respond adequately to fluid therapy despite improvements in systemic hemodynamic parameters, suggesting a dissociation between systemic and renal hemodynamics [94]. Although fluid administration is the first-line treatment for hypotensive conditions during surgery, it may promote hemodilution, induce anemia, and reduce oxygen-carrying capacity. Hemodilution after fluid administration decreases blood viscosity, leading to modifications in capillary density and resulting in reduced oxygen transport at the tissue level [21]. These changes may reduce renal perfusion and consequently lead to renal hypoxia and AKI, even after optimizing the cardiac output [95]. Several studies have shown that fluid administration significantly improves organ perfusion in patients with microcirculatory dysfunction at baseline, but not in those with normal organ perfusion despite normalization of systemic hemodynamic parameters and cardiac output [96]. In this scenario, the use of specific tools to evaluate microcirculation and tissue oxygen delivery, such as functional capillary density, capillary hematocrit, and red blood cell velocity, may enhance our ability to assess which patients will benefit from fluid administration [97]. In this context, fluid administration should be individualized for each patient based on their condition and the phase of critical illness.

Conclusion

In surgical procedures involving pneumoperitoneum, compromised renal function results from complex pathophysiological mechanisms, including induced abdominal hypertension, varying CO₂ levels, and neuroendocrine activation. These in turn diminish intraoperative renal perfusion, which may not adequately correlate with the loss of renal autoregulation. Future research should focus on elucidating the specific pathophysiological mechanisms and exploring the utility of biomarkers. Such efforts are essential for developing a comprehensive care bundle tailored to preventing renal function decline, particularly in individuals with a diminished RFR.

Funding

None.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Data Availability

All data generated or analyzed during this study are included in this published article.

Author Contributions

Gianluca Villa (Writing – review & editing)

Marco Fiorentino (Writing – original draft; Writing – review & editing)

Eleonora Cappellini (Writing – original draft; Writing – review & editing)

Sergio Lassola (Writing – original draft; Writing – review & editing)

Silvia De Rosa (Conceptualization; Writing – original draft; Writing – review & editing)

Fig. 1.

Neuroendocrine and renal effects of pneumoperitoneum. These figures outline neuroendocrine responses (e.g., sympathetic activation and hormonal fluctuations) and renal changes (e.g., reduced blood flow and altered filtration rates) during pneumoperitoneum. These effects underscore the physiological effects of laparoscopic surgery on the neuroendocrine and renal systems and reflect potential clinical implications. NSAID: non-steroidal anti-inflammatory drug, RBF: renal blood flow.

Fig. 2.

Pathophysiology of kidney damage during laparoscopic surgery. ADH: antidiuretic hormone.

Table 1.

Risk Factors and Bundles for Acute Kidney Injury

	Risk factor	Bundle	Preventive anesthesiologic strategies
Preoperative risk factors for AKI	Dehydration	Inadequate fluid intake or excessive fluid loss, leading to reduced renal perfusion and function.	Fluid management
	Older age	Advanced age correlates with RFR, heightening susceptibility to AKI.	Geriatric assessment
	Hypertension	Chronic hypertension induces arteriolar sclerosis and renal vascular changes, reducing renal perfusion and function, increasing susceptibility to AKI.	Adequate blood pressure management
	History of diabetes mellitus	Diabetes induces microvascular changes in kidneys, escalating susceptibility to AKI.	Adequate diabetes management
	Pre-existing CKD	Patients with pre-existing CKD exhibit impaired renal function, characterized by reduced GFR and nephron loss, increasing vulnerability to AKI.	CKD assessment
	Use of renin-angiotensin-aldosterone system inhibitors	Medications such as ACE inhibitors and ARBs alter renal hemodynamics, causing renal vasodilation and potentially reducing renal perfusion, increasing the risk of AKI.	Medication review
	High BMI	Elevated BMI is associated with increased intra-abdominal pressure, impairing renal perfusion and function.	Obesity assessment
	Preoperative hypoalbuminemia	Low serum albumin levels signify compromised nutritional status and may correlate with renal dysfunction, predisposing to AKI.	Nutritional assessment
Intraoperative/postoperative risk factors for AKI	Elevated IAP	Increased IAP during laparoscopic procedures compromises renal perfusion, predisposing to AKI.	Maintain adequate intra-abdominal pressure
	Hypovolemia	Reduced blood volume can lead to decreased renal perfusion and function.	Fluid replacement
	Prolonged time of the laparoscopic procedure	Longer duration of surgery may increase the risk of AKI due to prolonged exposure to anesthesia and altered hemodynamics.	Mainysin adequate surgical duration
	Decreased cardiac output	Reduced heart function leads to decreased blood flow to the kidneys, potentially causing AKI.	Hemodynamic monitoring
	Exposure to nephrotoxic drugs	Drugs with nephrotoxic effects may directly damage renal tissues, increasing the risk of AKI.	Avoidance and minimization of the duration of exposure

AKI: acute kidney injury, RFR: renal functional reserve, CKD: chronic kidney disease, GFR: glomerular filtration rate, ACE: angiotensin-converting enzyme, ARB: angiotensin II receptor blockers, BMI: body mass index, IAP: intra-abdominal pressure.

References

1. Özdemir-van Brunschot DM, van Laarhoven KC, Scheffer GJ, Pouwels S, Wever KE, Warlé MC. What is the evidence for the use of low-pressure pneumoperitoneum? A systematic review. Surg Endosc 2016; 30: 2049-65.

2. Wever KE, Bruintjes MH, Warlé MC, Hooijmans CR. Renal perfusion and function during pneumoperitoneum: a systematic review and meta-analysis of animal studies. PLoS One 2016; 11: e0163419.

3. Kim M, Brady JE, Li G. Variations in the risk of acute kidney injury across intraabdominal surgery procedures. Anesth Analg 2014; 119: 1121-32.

4. Kheterpal S, Tremper KK, Englesbe MJ, O’Reilly M, Shanks AM, Fetterman DM, et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007; 107: 892-902.

5. Teixeira C, Rosa R, Rodrigues N, Mendes I, Peixoto L, Dias S, et al. Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract 2014; 2014: 132175.

6. Long TE, Helgason D, Helgadottir S, Palsson R, Gudbjartsson T, Sigurdsson GH, et al. Acute kidney injury after abdominal surgery: Incidence, risk factors, and outcome. Anesth Analg 2016; 122: 1912-20.

7. Sim JH, Kang SJ, Bang JY, Song JG. Comparison of the effects of laparoscopic and open surgery on postoperative acute kidney injury in patients with colorectal cancer: propensity score analysis. J Clin Med 2021; 10: 1438.

8. Abdullah HR, Tan TP, Vaez M, Deb C, Farag N, Jackson TD, et al. Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery: a single-centre retrospective cohort study. Obes Surg 2016; 26: 1493-9.

9. Srisawat N, Kongwibulwut M, Laoveeravat P, Lumplertgul N, Chatkaew P, Saeyub P, et al. The role of intraoperative parameters on predicting laparoscopic abdominal surgery associated acute kidney injury. BMC Nephrol 2018; 19: 289.

10. Tang Y, Li B, Ouyang W, Jiang G, Tang H, Liu X. Intraoperative hypertension is associated with postoperative acute kidney injury after laparoscopic surgery. J Pers Med 2023; 13: 541.

11. Paek JH, Kang SI, Ryu J, Lim SY, Ryu JY, Son HE, et al. Renal outcomes of laparoscopic versus open surgery in patients with rectal cancer: a propensity score analysis. Kidney Res Clin Pract 2021; 40: 634-44.

12. Park YS, Jun IG, Go Y, Song JG, Hwang GS. Comparison of acute kidney injury between open and laparoscopic pylorus-preserving pancreaticoduodenectomy: propensity score analysis. PLoS One 2018; 13: e0202980.

13. Moon YJ, Jun IG, Kim KH, Kim SO, Song JG, Hwang GS. Comparison of acute kidney injury between open and laparoscopic liver resection: propensity score analysis. PLoS One 2017; 12: e0186336.

14. Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2: 1-138.

15. Gurusamy KS, Vaughan J, Davidson BR. Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database Syst Rev 2014; 2014: CD006930.

16. Baxter JN, O’Dwyer PJ. Pathophysiology of laparoscopy. Br J Surg 1995; 82: 1-2.

17. Safran DB, Orlando R 3rd. Physiologic effects of pneumoperitoneum. Am J Surg 1994; 167: 281-6.

18. Speller AM, Moffat DB. Tubulo-vascular relationships in the developing kidney. J Anat 1977; 123: 487-500.

19. Demyttenaere S, Feldman LS, Fried GM. Effect of pneumoperitoneum on renal perfusion and function: a systematic review. Surg Endosc 2007; 21: 152-60.

20. Bilgic T, Narter F. Effects of pneumoperitoneum with carbon dioxide on renal and hepatic functions in rats. Wideochir Inne Tech Maloinwazyjne 2020; 15: 574-82.

21. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210-21.

22. Dalal R, Sehdev JS. Physiology, Renal, Blood Flow and Filtration. StatPearls. 2018, Available from https://www.ncbi.nlm.nih.gov/books/NBK482248/.

23. Bishara B, Karram T, Khatib S, Ramadan R, Schwartz H, Hoffman A, et al. Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine. Surg Endosc 2009; 23: 568-76.

24. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurgery 1993; 14: 165-75.

25. Jang HR, Ko GJ, Wasowska BA, Rabb H. The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med (Berl) 2009; 87: 859-64.

26. Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev 2015; 4: 20-7.

27. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-64.

28. Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 2007; 18: 414-20.

29. Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol 2012; 2: 1303-53.

30. Linkermann A, Stockwell BR, Krautwald S, Anders HJ. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol 2014; 14: 759-67.

31. Hall AM, Rhodes GJ, Sandoval RM, Corridon PR, Molitoris BA. In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury. Kidney Int 2013; 83: 72-83.

32. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008; 134: 112-23.

33. Clark AJ, Parikh SM. Mitochondrial metabolism in acute kidney injury. Semin Nephrol 2020; 40: 101-13.

34. Eaton S, McHoney M, Giacomello L, Pacilli M, Bishay M, De Coppi P, et al. Carbon dioxide absorption and elimination in breath during minimally invasive surgery. J Breath Res 2009; 3: 047005.

35. Rammohan A, Manimaran AB, Manohar RR, Naidu RM. Nitrous oxide for pneumoperitoneum: no laughing matter this! A prospective single blind case controlled study. Int J Surg 2011; 9: 173-6.

36. Gutt CN, Oniu T, Mehrabi A, Schemmer P, Kashfi A, Kraus T, et al. Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg 2004; 21: 95-105.

37. Gunatilake DE. Case report: fatal intraperitoneal explosion during electrocoagulation via laparoscopy. Int J Gynaecol Obstet 1978; 15: 353-7.

38. Yang X, Cheng Y, Cheng N, Gong J, Bai L, Zhao L, et al. Gases for establishing pneumoperitoneum during laparoscopic abdominal surgery. Cochrane Database Syst Rev 2022; 3: CD009569.

39. Trondsen E, Reiertsen O, Andersen OK, Kjaersgaard P. Laparoscopic and open cholecystectomy. A prospective, randomized study. Eur J Surg 1993; 159: 217-21.

40. Ure BM, Niewold TA, Bax NM, Ham M, van der Zee DC, Essen GJ. Peritoneal, systemic, and distant organ inflammatory responses are reduced by a laparoscopic approach and carbon dioxide versus air. Surg Endosc 2002; 16: 836-42.

41. Papparella A, Noviello C, Ranucci S, Paciello O, Papparella S, De Biase D, et al. Pneumoperitoneum modifies serum and tissue CCL2-CCL5 expression in mice. JSLS 2020; 24: e2020.00017.

42. Finnerty CC, Mabvuure NT, Ali A, Kozar RA, Herndon DN. The surgically induced stress response. JPEN J Parenter Enteral Nutr 2013; 37(5 Suppl): S21-9.

43. Hatipoglu S, Akbulut S, Hatipoglu F, Abdullayev R. Effect of laparoscopic abdominal surgery on splanchnic circulation: historical developments. World J Gastroenterol 2014; 20: 18165-76.

44. Mikami O, Fujise K, Matsumoto S, Shingu K, Ashida M, Matsuda T. High intra-abdominal pressure increases plasma catecholamine concentrations during pneumoperitoneum for laparoscopic procedures. Arch Surg 1998; 133: 39-43.

45. Cusack B, Buggy DJ. Anaesthesia, analgesia, and the surgical stress response. BJA Educ 2020; 20: 321-8.

46. Hazebroek EJ, de Vos tot Nederveen Cappel R, Gommers D, Van Gelder T, Weimar W, Steyerberg EW, et al. Antidiuretic hormone release during laparoscopic donor nephrectomy. Arch Surg 2002; 137: 600-4.

47. Mann C, Boccara G, Pouzeratte Y, Eliet J, Serradel-Le Gal C, Vergnes C, et al. The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changes. Anesth Analg 1999; 89: 278-83.

48. Grindstaff RR, Grindstaff RJ, Cunningham JT. Effects of right atrial distension on the activity of magnocellular neurons in the supraoptic nucleus. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1605-15.

49. Husain-Syed F, Ferrari F, Sharma A, Hinna Danesi T, Bezerra P, Lopez-Giacoman S, et al. Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery. Nephrol Dial Transplant 2019; 34: 308-17.

50. Cisek LJ, Gobet RM, Peters CA. Pneumoperitoneum produces reversible renal dysfunction in animals with normal and chronically reduced renal function. J Endourol 1998; 12: 95-100.

51. Abboud W, Bishara B, Nativ O, Awad H, Kinaneh S, Abu-Salah N. Impact of pneumoperitoneum on the development of acute kidney injury: comparison between normal and diabetic rats. Surg Laparosc Endosc Percutan Tech 2020; 31: 136-41.

52. de Seigneux S, Klopfenstein CE, Iselin C, Martin PY. The risk of acute kidney injury following laparoscopic surgery in a chronic kidney disease patient. NDT Plus 2011; 4: 339-41.

53. Lindström P, Wadström J, Ollerstam A, Johnsson C, Persson AE. Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat. Nephrol Dial Transplant 2003; 18: 2269-77.

54. Romagnoli S, Ricci Z, Ronco C. Perioperative acute kidney injury: prevention, early recognition, and supportive measures. Nephron 2018; 140: 105-10.

55. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet 2019; 394: 1949-64.

56. Vanmassenhove J, Glorieux G, Hoste E, Dhondt A, Vanholder R, Van Biesen W. Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis. Crit Care 2013; 17: R234.

57. Husain-Syed F, Reis T, Kashani K, Ronco C. Advances in laboratory detection of acute kidney injury. Pract Lab Med 2022; 31: e00283.

58. Melville RJ, Forsling ML, Frizis HI, Lequesne LP. Stimulus for vasopressin release during elective intra-abdominal operations. Br J Surg 1985; 72: 979-82.

59. Mendes RS, Suassuna J. Perioperative oliguria: adequate physiological response or risk for acute kidney injury? J Bras Nefrol 2021; 43: 1-2.

60. McDougall EM, Monk TG, Wolf JS Jr, Hicks M, Clayman RV, Gardner S, et al. The effect of prolonged pneumoperitoneum on renal function in an animal model. J Am Coll Surg 1996; 182: 317-28.

61. Nishio S, Takeda H, Yokoyama M. Changes in urinary output during laparoscopic adrenalectomy. BJU Int 1999; 83: 944-7.

62. Milder DA, Liang SS, Ong SG, Kam PC. Association between intraoperative oliguria and postoperative acute kidney injury in non-cardiac surgical patients: a systematic review and meta-analysis. J Anesth 2023; 37: 219-33.

63. Dunn MD, McDougall EM. Renal physiology. Laparoscopic considerations. Urol Clin North Am 2000; 27: 609-14.

64. Köckerling F. Robotic vs. Standard laparoscopic technique - what is better? Front Surg 2014; 1: 15.

65. Kuribayashi R, Suzumura H, Sairenchi T, Watabe Y, Tsuboi Y, Imataka G, et al. Urinary neutrophil gelatinase-associated lipocalin is an early predictor of acute kidney injury in premature infants. Exp Ther Med 2016; 12: 3706-10.

66. Lassnigg A, Schmid ER, Hiesmayr M, Falk C, Druml W, Bauer P, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008; 36: 1129-37.

67. Joo EY, Moon YJ, Yoon SH, Chin JH, Hwang JH, Kim YK. Comparison of acute kidney injury after robot-assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a propensity score matching analysis. Medicine (Baltimore) 2016; 95: e2650.

68. D’Alonzo RC, Gan TJ, Moul JW, Albala DM, Polascik TJ, Robertson CN, et al. A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy. J Clin Anesth 2009; 21: 322-8.

69. Shalabi A, Nativ O, Sumri M, Bishara B, Khoury W, Awad H, et al. Impact of pneumoperitoneum on the post-operative renal function and level of acute kidney injury markers: comparison between laparoscopic and open nephrectomy. Int Arch Urol Complicat 2017; 3: 026.

70. Orsolya M, Attila-Zoltan M, Gherman V, Zaharie F, Bolboaca S, Chira C, et al. The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology. J BUON 2015; 20: 317-24.

71. Sun W, Li F, Wang X, Liu H, Mo H, Pan D, et al. Effects of dexmedetomidine on patients undergoing laparoscopic surgery for colorectal cancer. J Surg Res 2021; 267: 687-94.

72. Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011; 15: R153.

73. Xie Y, Ankawi G, Yang B, Garzotto F, Passannante A, Breglia A, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury. Kidney Int 2019; 95: 1486-93.

74. Greco M, De Rosa S, Boehm F, Spano S, Aceto R, Voza A, et al. Kinetics of the cell cycle arrest biomarkers (TIMP2 and IGFBP7) for the diagnosis of acute kidney injury in Critically Ill COVID-19 patients. Diagnostics (Basel) 2023; 13: 317.

75. Golino G, Greco M, Rigobello A, Danzi V, De Cal M, Malchiorna N, et al. Incidence of Acute Kidney Injury in Polytrauma Patients and Predictive Performance of TIMP2 × IGFBP7 Biomarkers for Early Identification of Acute Kidney Injury. Diagnostics 2022; 12: 2481.

76. Forni LG, Joannidis M, Artigas A, Bell M, Hoste E, Joannes-Boyau O, et al. Characterising acute kidney injury: The complementary roles of biomarkers of renal stress and renal function. J Crit Care 2022; 71: 154066.

77. Godi I, De Rosa S, Martino F, Bazzano S, Martin M, Boni E, et al. Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients. Ann Intensive Care 2020; 10: 46.

78. Liu C, Lu X, Mao Z, Kang H, Liu H, Pan L, et al. The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2017; 96: e7484.

79. Lameire N, Van Biesen W, Hoste E, Vanholder R. The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI. NDT Plus 2008; 1: 392-402.

80. Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, et al. Perioperative Acute Kidney Injury. Anesthesiology 2020; 132: 180-204.

81. Mårtensson J, Bellomo R. Does fluid management affect the occurrence of acute kidney injury? Curr Opin Anaesthesiol 2017; 30: 84-91.

82. Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically Ill adults. N Engl J Med 2018; 378: 829-39.

83. Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, et al. Balanced crystalloids versus saline in noncritically Ill adults. N Engl J Med 2018; 378: 819-28.

84. Weisbord SD, Gallagher M, Kaufman J, Cass A, Parikh CR, Chertow GM, et al. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol 2013; 8: 1618-31.

85. Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 2018; 378: 603-14.

86. Fiorentino M, Castellano G, Kellum JA. Differences in acute kidney injury ascertainment for clinical and preclinical studies. Nephrol Dial Transplant 2017; 32: 1789-805.

87. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25.

88. Zarbock A, Küllmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg 2021; 133: 292-302.

89. Göcze I, Jauch D, Götz M, Kennedy P, Jung B, Zeman F, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg 2018; 267: 1013-20.

90. Ergin B, Kapucu A, Demirci-Tansel C, Ince C. The renal microcirculation in sepsis. Nephrol Dial Transplant 2015; 30: 169-77.

91. Bellomo R, Ronco C, Mehta RL, Asfar P, Boisramé-Helms J, Darmon M, et al. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference. Ann Intensive Care 2017; 7: 49.

92. Murugan R, Kazory A, Sgarabotto L, Ronco C. Fluid overload and precision net ultrafiltration in critically Ill patients. Cardiorenal Med 2023; 13: 9-18.

93. Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, et al. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 962-7.

94. Legrand M, Le Cam B, Perbet S, Roger C, Darmon M, Guerci P, et al. Urine sodium concentration to predict fluid responsiveness in oliguric ICU patients: a prospective multicenter observational study. Crit Care 2016; 20: 165.

95. Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76: 784-91.

96. Ferrara G, Kanoore Edul VS, Caminos Eguillor JF, Buscetti MG, Canales HS, Lattanzio B, et al. Effects of fluid and norepinephrine resuscitation in a sheep model of endotoxin shock and acute kidney injury. J Appl Physiol (1985) 2019; 127: 788-97.

97. Favaron E, Montomoli J, Hilty MP, Ince C. Fluid management in the perioperative setting: mind the kidney. J Emerg Crit Care Med 2019; 3: 50.